Log In
BCIQ
Print this Print this
 

CYC116

Also known as: Aurora kinase inhibitor

  Manage Alerts
Collapse Summary General Information
Company Cyclacel Pharmaceuticals Inc.
DescriptionAurora kinase A and B, and vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) inhibitor
Molecular Target Aurora kinase A (AURKA) (Aurora-A) ; Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor; Aurora kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today